Predicting mortality, thrombus recurrence and persistence in patients with post-acute myocardial infarction left ventricular thrombus
Name
11239_2020_2368_ReferencePDF.pdf
Size
648.49 KB
Format
Adobe PDF
Checksum (MD5)
b111104e8e660187fbb3cb00012aafd5
Author(s)
Yeung, Wesley
Sia, Ching-Hui
Pollard, Tom
Leow, Aloysius S.
Tan, Benjamin Y.
Kaur, Rajinderdeep
Yeo, Tiong-Cheng
Tay, Edgar L.
Yeo, Leonard L.
Chan, Mark Y.
Date Issued
January 2, 2021
Publisher
Springer US
Citation
Yeung, Wesley, Sia, Ching-Hui, Pollard, Tom, Leow, Aloysius S., Tan, Benjamin Y. et al. 2021. "Predicting mortality, thrombus recurrence and persistence in patients with post-acute myocardial infarction left ventricular thrombus."
Version
Author's final manuscript
Abstract
Abstract
Left ventricular thrombus (LVT) is a common complication of acute myocardial infarction and is associated with morbidity from embolic complications. Predicting which patients will develop death or persistent LVT despite anticoagulation may help clinicians identify high-risk patients. We developed a random forest (RF) model that predicts death or persistent LVT and evaluated its performance. This was a single-center retrospective cohort study in an academic tertiary center. We included 244 patients with LVT in our study. Patients who did not receive anticoagulation (n = 8) or had unknown (n = 31) outcomes were excluded. The primary outcome was a composite outcome of death, recurrent LVT and persistent LVT. We selected a total of 31 predictors collected at the point of LVT diagnosis based on clinical relevance. We compared conventional regularized logistic regression with the RF algorithm. There were 156 patients who had resolution of LVT and 88 patients who experienced the composite outcome. The RF model achieved better performance and had an AUROC of 0.700 (95% CI 0.553–0.863) on a validation dataset. The most important predictors for the composite outcome were receiving a revascularization procedure, lower visual ejection fraction (EF), higher creatinine, global wall motion abnormality, higher prothrombin time, higher body mass index, higher activated partial thromboplastin time, older age, lower lymphocyte count and higher neutrophil count. The RF model accurately identified patients with post-AMI LVT who developed the composite outcome. Further studies are needed to validate its use in clinical practice.
MIT Department
Harvard University--MIT Division of Health Sciences and Technology
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1007/s11239-020-02368-1
